Implications of exercise-induced pulmonary arterial hypertension

Medicine and Science in Sports and Exercise

Volumn 43, Issue 6, 2011, Pages 983-989

  Fowler, Robin M ^a,b,c   Maiorana, Andrew J ^a,b   Jenkins, Sue C ^b,c,d   Gain, Kevin R ^a,b,c   O'Driscoll, Gerry ^c,e,f   Gabbay, Eli ^a,b,c,e,f,g  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e UNIVERSITY OF NOTRE DAME   (Australia)

^f Heart and Lung Transplant Foundation of Western Australia   (Australia)

^g Heart and Lung Transplant Foundation of Western Australia ^*  (Australia)

Author keywords

Exercise; hemodynamics; pulmonary circulation; quality of life

Indexed keywords

CARBON DIOXIDE;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CATHETER; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART OUTPUT; HUMAN; LUNG VENTILATION; LUNG WEDGE PRESSURE; MALE; METABOLISM; MIDDLE AGED; MONITORING; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; PULMONARY HYPERTENSION; QUALITY OF LIFE; VASCULAR RESISTANCE;

ADULT; AGE FACTORS; CARBON DIOXIDE; CARDIAC OUTPUT; CASE-CONTROL STUDIES; CATHETERS; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OXYGEN CONSUMPTION; PULMONARY ARTERY; PULMONARY VENTILATION; PULMONARY WEDGE PRESSURE; QUALITY OF LIFE; VASCULAR RESISTANCE;

EID: 79958015279     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e318204cdac     Document Type: Article

References (26)

1. American Thoracic Society. ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med. 2002;166:111-117.
2. Condliffe R, Kiely DG, Peacock A, et al. Connective tissue disease- associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009;179:151-157.
3. Cotes JE, Chinn DJ, Quanjer Ph H, Roca J, Yernault Y-C. Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J. 1993;6(16 suppl):41-52. (Pubitemid 23116783)
4. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115:343-349.
5. Hansen JE, Ulubay G, Chow BF, Sun X-G, Wasserman K. Mixedexpired and end-tidal CO2 distinguish between ventilation and perfusion defects during exercise testing in patients with lung and heart diseases. Chest. 2007;132:977-983.
6. Hatano S, Strasser T. Primary Pulmonary Hypertension: Report on a WHO Meeting. Geneva, 15-17 Oct 1973. Albany, NY: Q Corporation; .1975. p. 41.
7. James KB, Maurer J, Wolski K, et al. Exercise hemodynamic findings in patients with exertional dyspnea. Tex Heart Inst J. 2000;27:100-105. (Pubitemid 30464034)
8. Jones NL, Makrides L, Hitchcock C, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis. 1985;131:700-708. (Pubitemid 15066853)
9. Keogh AM, McNeil KD, Wlodarczyk J, Gabbay E, Williams TJ. Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan. J Heart Lung Transplant. 2007;26: 181-187. (Pubitemid 46136035)
10. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009;34:888-894.
11. Kovacs G, Maier R, Aberer E, et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med. 2009;180:881-886.
12. Markowitz DH, Systrom DM. Diagnosis of pulmonary vascular limit to exercise by cardiopulmonary exercise testing. J Heart Lung Transplant. 2004;23:88-95. (Pubitemid 38084833)
13. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association. Circulation. 2009;119:2250-2294.
14. McLaughlin VV, Sitbon O, Badesch DB, et al. Survival with firstline bosentan in patients with primary pulmonary hypertension. Eur Respir J. 2005;25:244-249. (Pubitemid 40246523)
15. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003; 62:1088-1093. (Pubitemid 37323574)
16. Park MH, Ramani GV, Kop WJ, Uber PA, Mehra MR. Exerciseuncovered pulmonary arterial hypertension and pharmacologic therapy: clinical benefits. J Heart Lung Transplant. 2009;29:228-229.
17. Phung S, Strange G, Chung LP, et al. Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Int Med J. 2009;39:682-691.
18. Raeside DA, Chalmers G, Clelland J, Madhok R, Peacock AJ. Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring. Thorax. 1998;53:857-862. (Pubitemid 28459542)
19. Raeside DA, Smith A, Brown A, et al. Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension. Eur Respir J. 2000;16:282-287. (Pubitemid 30624947)
20. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001;119: 256-270. (Pubitemid 32150576)
21. Sun X, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104:429-435. (Pubitemid 32678273)
22. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom D. Exercise-induced pulmonary arterial hypertension. Circulation. 2008;118:2183-2189.
23. Walkey AJ, Ieong M, Alikhan M, Farber HW. Cardiopulmonary exercise testing with right-heart catheterization in patients with systemic sclerosis. J Rheumatol. 2010;37:1871-1877.
24. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Principles of Exercise Testing and Interpretation. Philadelphia (PA): Lippincott Williams & Wilkins; 2005. p. 187, 216.
25. Williams MH, Das C, Handler CE, et al. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart. 2005;92:926-932.
26. Yasunobu Y, Oudiz RJ, Sun X-G, Hansen JE, Wasserman K. Endtidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest. 2005;127:1637-1646. (Pubitemid 46218789)